-
Founded in:
1993-09-09 -
Country:
China -
Address:
No. 22 Lianfeng Road, Zhuhai Free Trade Zone -
Tax NO.:
91440400617499024L -
Registered Funds:
128.28 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| CeftazidiMe |
A semisynthetic third-generation cephalosporin
More
A semisynthetic third-generation cephalosporin |
72558-82-8 | 27 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Irbesartan |
Not described in detail
More
Not described in detail |
138402-11-6 | 65 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Piperacillin sodium salt |
Piperacillin is a broad-spectrum semisynthetic penicillin antibiotic that has antibacterial effects on piperacillin-sensitive bacteria and bacteria that are resistant to piperacillin due to the production of beta-lactamase.
More
Piperacillin is a broad-spectrum semisynthetic penicillin antibiotic that has antibacterial effects on piperacillin-sensitive bacteria and bacteria that are resistant to piperacillin due to the production of beta-lactamase. |
59703-84-3 | 17 | |
| Tazobactam sodium |
Tazobactam is a new type of irreversible competitive beta-lactamase inhibitor that has antibacterial effects on bacteria that are resistant to piperacillin due to the production of beta-lactamase.
More
Tazobactam is a new type of irreversible competitive beta-lactamase inhibitor that has antibacterial effects on bacteria that are resistant to piperacillin due to the production of beta-lactamase. |
89785-84-2 | 9 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Omeprazole sodium |
This product is a proton pump inhibitor for gastric parietal cells. It can specifically inhibit the secretory microtubules and tubular vesicles in the cytoplasm of the parietal cell apical membrane, thereby effectively inhibiting the secretion of gastric acid. Since H, K-ATPase is the last process of acid secretion by parietal cells, this product has a strong acid-suppressing ability. It can not only non-competitively inhibit gastric acid secretion caused by gastrin, histamine, choline and food stimulation of the vagus nerve, but also inhibit part of the basal gastric acid secretion that is not affected by choline or H2 receptor blockers. It also has a strong and lasting inhibitory effect on gastric acid secretion caused by dibutyl cyclic adenosine monophosphate (DCAMP) stimulation that cannot be inhibited by H2 receptor antagonists. This product also has an inhibitory effect on pepsin secretion and has an effect on changes in gastric mucosal blood flow.
More
This product is a proton pump inhibitor for gastric parietal cells. It can specifically inhibit the secretory microtubules and tubular vesicles in the cytoplasm of the parietal cell apical membrane, thereby effectively inhibiting the secretion of gastric acid. Since H, K-ATPase is the last process of acid secretion by parietal cells, this product has a strong acid-suppressing ability. It can not only non-competitively inhibit gastric acid secretion caused by gastrin, histamine, choline and food stimulation of the vagus nerve, but also inhibit part of the basal gastric acid secretion that is not affected by choline or H2 receptor blockers. It also has a strong and lasting inhibitory effect on gastric acid secretion caused by dibutyl cyclic adenosine monophosphate (DCAMP) stimulation that cannot be inhibited by H2 receptor antagonists. This product also has an inhibitory effect on pepsin secretion and has an effect on changes in gastric mucosal blood flow. |
95510-70-6 | 25 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Fluvoxamine maleate |
Extract from the above information
More
Extract from the above information |
61718-82-9 | 28 |